China Phamaceuticals & Health Technologies Weekly (Aug. 5, 2010 – Aug. 11, 2010).pdf
Interfax China Pharmaceuticals 200 tons of sulbactam powder for injection; 50 tons of penicillamine powder for injection; 100 million doses of penicillin lyophilized powder; and 100 million doses of cephalosporin lyophilized powder. The first phase of the facility will be operational in December 2012. The company expects it to generate annual sales revenue of RMB 1.22 billion ($180.32 million). www.interfax.com 15 Interfax China Pharmaceuticals and how mergers and acquisitions (M & A) and collaborations and alliances can help shorten R & D cycles, simplify operational proc- esses and drive business growth. Time: Sept. 16 Sept. 17 Location: Shanghai Marriott Hotel Changfeng Park Hosting Organization: China Decision Makers Consultancy (CDMC) Website: http:/www.ph-focus.com/index.asp Contact: Judy Liu (Conference Manager) Tel: +86 21 6840 7631 ext. 8015 Fax: +86 21 6840 7632 E-mail: PFC2010marketing.chinadecisionmakers.com www.interfax.com 28 Interfax China Pharmaceuticals & Health Technologies Weekly, Aug. 5, 2010 Aug. 11, 2010 28 WEEKLY MONITORS - CHINA WEEKLY MONITORS - China Keep up-to-date with breaking developments within your target industries in China with Inter- fax China's authoritative industry weeklies. China Investment Weekly China Pharmaceuticals & Health Technologies Weekly China Energy Weekly China TMT Weekly China Mining and Metals Weekly www.interfax.com 29 Interfax China Pharmaceuticals & Health Technologies Weekly, Aug. 5, 2010 Aug. 11, 2010 29 INDUSTRY REPORTS - CHINA Industry-specific Reports Strengthen your China strategy through in-depth analysis and intelligence through special re- ports, tailored custom research, and periodic industry monitoring. China Carbon Trading Market up to 2012 Clean & Renewable Energy in China up to 2010 Pharmaceutical Outsourcing in China Looking Ahead China's Online and Mobile Gaming up to 2010 China's Aluminum Fabrication Industry up to 2010 China Commodities Report: Grains and Softs 2008 www.interfax.com 30 Interfax China Pharmaceuticals & Health Technologies Weekly, Aug. 5, 2010 Aug. 11, 2010 30 RESEARCH SERVICES Custom Research Sound China strategy is built upon sound insight. Fully understanding China's shifting terrain is an absolute prerequisite for success. Our team of business specialists focuses directly on your needs to conduct in-depth investigations to provide tailored intelligence and analysis. Utilize our China expertise to ensure a solid foundation for your strategy in a wide variety of applications, including mergers and acquisitions, China entry, strategic business planning, new product launches and development, investment and funding analysis, due diligence and market intelligence, among others. Contact us Contact our research team for a full assessment of how we can use our accumulated China industry experience and unparalleled industry network to your full advantage. Email: Cynthia.wonginterfax-news.com Phone: (852) 2537 2263 Fax: (852) 2537 2264 The information contained here is believed to be fully reliable, but is provided for information purposes only with no warranty expressed or implied. The user shall fully indemnify and hold harmless Interfax Information Services B.V. and any of its Affiliates against any judgment, liability, loss, cost or damage resulting from or aris- ing out of the content the information and recommendations contained herein, as they are not to be used or considered as an offer to sell, or a solicitation of an offer to buy, or related to any omissions, delays, errors or inaccuracies. #
